LUPUS MYOSITIS

LUPUS MYOSITIS was reported 9 times

LUPUS MYOSITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Type I Interferon Receptor Antagonist [EPC] 1 0.0005
1 B Lymphocyte Stimulator-specific Inhibitor [EPC] 2 0.0001
2 Vitamin D3 Analog [EPC] 1 0.0000
3 Human Immunoglobulin G [EPC] 1 0.0000
4 Interleukin-17A Antagonist [EPC] 1 0.0000
5 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
6 Vitamin D [EPC] 1 0.0000
7 Vitamin B12 [EPC] 1 0.0000
8 Vitamin C [EPC] 1 0.0000
9 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
10 Corticosteroid [EPC] 1 0.0000